Clinical trial
Study of Outcomes of Radiofrequency Ablation of Lung Tumors
NCT00280189 · University of Pittsburgh, Other · Suspended
Key facts
| NCT number | NCT00280189 |
|---|---|
| Title | Study of Outcomes of Radiofrequency Ablation of Lung Tumors |
| Official title | A Prospective Study of Outcomes of Radiofrequency Ablation of Lung Tumors |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | RITA Medical Systems Industry |
| Status | Suspended |
| Study type | Observational |
| Conditions | NSCLC, Pulmonary Metastases |
| Intervention type | Behavioral, Procedure |
| Interventions | Radiofrequency ablation of pulmonary malignancies, Quality of life assessment, Assessment of pain |
| Enrollment | 72 |
| Start date | Sep 1, 2003 |
| Primary completion | Dec 1, 2025 |
| Completion | Feb 1, 2026 |
| First posted | Jan 20, 2006 |
| Last update posted | Apr 16, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: